Retina Gallery ~ Full Sized Retina Images

Library of Free, Non-Copyrighted Retina Images and Videos

Choose your language:
Last additions

mactel_shbea_071519_16.jpg
Macular Telangiectasia - Mild38 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
mactel_shbea_071519_15.jpg
Macular Telangiectasia - Mild39 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
mactel_shbea_071519_13.jpg
Macular Telangiectasia - Mild3 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
mactel_shbea_071519_12.jpg
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
mactel_shbea_071519_08.jpg
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
mactel_shbea_071519_09.jpg
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
mactel_shbea_071519_10.jpg
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
mactel_shbea_071519_07.jpg
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
mactel_shbea_071519_02.png
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
mactel_shbea_071519_06.jpg
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
mactel_shbea_071519_05.jpg
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
mactel_shbea_071519_04.jpg
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
mactel_shbea_071519_01.png
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
mactel_shbea_071519_03.jpg
Macular Telangiectasia - Mild2 views56 year old female with good vision and mild macular telangiectasia. VA 20/40 OD 20/16 OSDec 30, 2019
ga-jobau_031919_17~0.jpg
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
ga-jobau_031919_16~0.jpg
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
ga-jobau_031919_13~0.jpg
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
ga-jobau_031919_15~0.jpg
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
ga-jobau_031919_12~0.jpg
Concentric Geographic Atrophy - 76 year old man4 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
ga-jobau_031919_14~0.jpg
Concentric Geographic Atrophy - 76 year old man2 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
ga-jobau_031919_11~0.jpg
Concentric Geographic Atrophy - 76 year old man2 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
ga-jobau_031919_10~0.jpg
Concentric Geographic Atrophy - 76 year old man2 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
ga-jobau_031919_05~0.png
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
ga-jobau_031919_09~0.jpg
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
ga-jobau_031919_08~0.jpg
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
ga-jobau_031919_07~0.jpg
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
ga-jobau_031919_06~0.jpg
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
ga-jobau_031919_01~0.png
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
ga-jobau_031919_02~0.png
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
ga-jobau_031919_04~0.png
Concentric Geographic Atrophy - 76 year old man3 viewsGradual vision loss, worse at night. VA 20/40 OU.Dec 30, 2019
Asteroid_02.png
Asteroid Hyalosis - Clarus Color Image2 viewsDec 30, 2019
Asteroid_01.png
Asteroid Hyalosis - Clarus Color Image2 viewsDec 30, 2019
PDR-DME_arste_100719_02.png
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_28.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_27.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_26.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_25.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_24.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_23.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_22.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_21.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_01.png
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_20.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_19.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_18.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_17.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_16.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_15.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_14.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_13.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_12.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_11.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_10.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_09.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_08.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_07.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_06.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_05.JPG
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_04.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
PDR-DME_arste_100719_03.jpg
PDR and DME and VH2 views57 year old diabetic man with vision loss in the left eye for several months. He has DME in the left eye and VH in the left eye and PDR in both eyes. He has been started in the left eye on Anti-VEGF therapy. VA on presentation was 20/25 OD and 20/200 OSDec 30, 2019
pic_CNVM-jewal_020619andlater37.JPG
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater38.JPG
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater39.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater32.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater36.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater35.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater34.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater31.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater27.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater30.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater29.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater28.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater23.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater26.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater20.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater25.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater24.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane4 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater22.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater21.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater19.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater18.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater17.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater15.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater16.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater14.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater13.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater06.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater12.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater11.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater10.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater09.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater04.JPG
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater08.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater07.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater05.jpg
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater02.JPG
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane3 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater01.JPG
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
pic_CNVM-jewal_020619andlater03.JPG
Punctate Inner Choroidopathy and Choroidal Neovascular Membrane2 views27 year old female with vision loss for 4 months. VA was 20/200. She had a CNVM which was extrafoveal with no subretinal fluid. Her vision improved over 6 months to 20/50 with Ranibizumab injections (she might have improved without treatment)Dec 30, 2019
angiod_benner_18.jpg
Angioid Streaks Scar and new CNVM9 views49 y/o WF with decreased vision x 1 month. Her OD is 20/400 and her OS is seeing 20/70. No cutaneous lesions or Ehlers-Danlos. The FP and FA show a predominant classic CNV (with fibrosis) OD and an Occult CNV OS with what appears to be a RAP lesion.Dec 21, 2019
angiod_benner_16.jpg
Angioid Streaks Scar and new CNVM9 views49 y/o WF with decreased vision x 1 month. Her OD is 20/400 and her OS is seeing 20/70. No cutaneous lesions or Ehlers-Danlos. The FP and FA show a predominant classic CNV (with fibrosis) OD and an Occult CNV OS with what appears to be a RAP lesion.Dec 21, 2019
12245 files on 123 page(s) 1